PERKINELMER INC (PKI) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:PKI - US7140461093 - Common Stock
115.24 USD
-1.06 (-0.91%)
115.24 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to PKI. PKI was compared to 57 industry peers in the Life Sciences Tools & Services industry. PKI scores excellent on profitability, but there are some minor concerns on its financial health. PKI has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
PKI had positive earnings in the past year.
In the past year PKI had a positive cash flow from operations.
PKI had positive earnings in each of the past 5 years.
Each year in the past 5 years PKI had a positive operating cash flow.
1.2 Ratios
PKI has a better Return On Assets (5.28%) than 76.19% of its industry peers.
Looking at the Return On Equity, with a value of 10.11%, PKI is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
With a decent Return On Invested Capital value of 6.49%, PKI is doing good in the industry, outperforming 73.02% of the companies in the same industry.
PKI had an Average Return On Invested Capital over the past 3 years of 52.37%. This is significantly above the industry average of 13.99%.
The last Return On Invested Capital (6.49%) for PKI is well below the 3 year average (52.37%), which needs to be investigated, but indicates that PKI had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 10.11% | ||
| ROIC | 6.49% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of PKI (16.32%) is better than 82.54% of its industry peers.
PKI's Profit Margin has improved in the last couple of years.
PKI has a Operating Margin of 23.43%. This is amongst the best in the industry. PKI outperforms 88.89% of its industry peers.
PKI's Operating Margin has improved in the last couple of years.
PKI's Gross Margin of 58.39% is fine compared to the rest of the industry. PKI outperforms 76.19% of its industry peers.
PKI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.43% | ||
| PM (TTM) | 16.32% | ||
| GM | 58.39% |
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PKI is creating value.
Compared to 1 year ago, PKI has about the same amount of shares outstanding.
PKI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.51 indicates that PKI is not a great score, but indicates only limited risk for bankruptcy at the moment.
PKI has a Altman-Z score (2.51) which is in line with its industry peers.
PKI has a debt to FCF ratio of 7.40. This is a slightly negative value and a sign of low solvency as PKI would need 7.40 years to pay back of all of its debts.
PKI has a Debt to FCF ratio of 7.40. This is in the better half of the industry: PKI outperforms 77.78% of its industry peers.
PKI has a Debt/Equity ratio of 0.53. This is a neutral value indicating PKI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.53, PKI is doing worse than 68.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 7.4 | ||
| Altman-Z | 2.51 |
ROIC/WACC0.65
WACC10.02%
2.3 Liquidity
PKI has a Current Ratio of 2.13. This indicates that PKI is financially healthy and has no problem in meeting its short term obligations.
PKI's Current ratio of 2.13 is on the low side compared to the rest of the industry. PKI is outperformed by 68.25% of its industry peers.
PKI has a Quick Ratio of 1.87. This is a normal value and indicates that PKI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.87, PKI is doing worse than 65.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.87 |
3. Growth
3.1 Past
PKI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.47%.
Measured over the past years, PKI shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.15% on average per year.
PKI shows a decrease in Revenue. In the last year, the revenue decreased by -3.37%.
The Revenue has been growing slightly by 7.97% on average over the past years.
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%
3.2 Future
Based on estimates for the next years, PKI will show a small growth in Earnings Per Share. The EPS will grow by 6.04% on average per year.
The Revenue is expected to decrease by -8.60% on average over the next years.
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 14.51, which indicates a correct valuation of PKI.
96.83% of the companies in the same industry are more expensive than PKI, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.34, PKI is valued a bit cheaper.
The Price/Forward Earnings ratio is 22.11, which indicates a rather expensive current valuation of PKI.
Based on the Price/Forward Earnings ratio, PKI is valued a bit cheaper than 77.78% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.56, PKI is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.51 | ||
| Fwd PE | 22.11 |
4.2 Price Multiples
93.65% of the companies in the same industry are more expensive than PKI, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PKI indicates a rather cheap valuation: PKI is cheaper than 87.30% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.52 | ||
| EV/EBITDA | 12.35 |
4.3 Compensation for Growth
The excellent profitability rating of PKI may justify a higher PE ratio.
PKI's earnings are expected to decrease with -4.57% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.66
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
5. Dividend
5.1 Amount
PKI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
115.24
-1.06 (-0.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners86.56%
Inst Owner Change9.24%
Ins Owners0.81%
Ins Owner Change0%
Market Cap14.57B
Revenue(TTM)4.57B
Net Income(TTM)746.14M
Analysts73
Price Target159.39 (38.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP4.74%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.02%
Min EPS beat(2)2.33%
Max EPS beat(2)3.7%
EPS beat(4)4
Avg EPS beat(4)8.57%
Min EPS beat(4)2.33%
Max EPS beat(4)14.5%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-29.78%
Min Revenue beat(2)-30.42%
Max Revenue beat(2)-29.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-30.42%
Max Revenue beat(4)52.86%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.68%
PT rev (3m)-2.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.51 | ||
| Fwd PE | 22.11 | ||
| P/S | 3.19 | ||
| P/FCF | 24.52 | ||
| P/OCF | 21.43 | ||
| P/B | 1.97 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.35 |
EPS(TTM)7.94
EY6.89%
EPS(NY)5.21
Fwd EY4.52%
FCF(TTM)4.7
FCFY4.08%
OCF(TTM)5.38
OCFY4.67%
SpS36.16
BVpS58.4
TBVpS-19.59
PEG (NY)N/A
PEG (5Y)0.66
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 10.11% | ||
| ROCE | N/A | ||
| ROIC | 6.49% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 35.96% | ||
| OM | 23.43% | ||
| PM (TTM) | 16.32% | ||
| GM | 58.39% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
ROICexc(3y)8.57%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0.99%
ROICexgc growth 5Y-8%
ROICexc growth 3Y-3.25%
ROICexc growth 5Y0.67%
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
F-Score7
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 7.4 | ||
| Debt/EBITDA | 2.93 | ||
| Cap/Depr | 20.05% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 79.63% | ||
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.87 | ||
| Altman-Z | 2.51 |
F-Score7
WACC10.02%
ROIC/WACC0.65
Cap/Depr(3y)26.47%
Cap/Depr(5y)33.81%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)118.43%
Profit Quality(5y)114.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
EBIT growth 1Y-24.58%
EBIT growth 3Y25.31%
EBIT growth 5Y20.49%
EBIT Next Year-23.7%
EBIT Next 3Y-3.21%
EBIT Next 5Y3.97%
FCF growth 1Y-54.67%
FCF growth 3Y28.17%
FCF growth 5Y18.96%
OCF growth 1Y-51.81%
OCF growth 3Y23.2%
OCF growth 5Y18.7%
PERKINELMER INC / PKI FAQ
What is the ChartMill fundamental rating of PERKINELMER INC (PKI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to PKI.
What is the valuation status for PKI stock?
ChartMill assigns a valuation rating of 7 / 10 to PERKINELMER INC (PKI). This can be considered as Undervalued.
Can you provide the profitability details for PERKINELMER INC?
PERKINELMER INC (PKI) has a profitability rating of 3 / 10.
Can you provide the financial health for PKI stock?
The financial health rating of PERKINELMER INC (PKI) is 4 / 10.
Is the dividend of PERKINELMER INC sustainable?
The dividend rating of PERKINELMER INC (PKI) is 0 / 10 and the dividend payout ratio is 4.74%.